Synthetic nicotine has arrived
Abstract
<jats:p>The introduction of a new product line of the popular disposable electronic
cigarette brand Puffbar, advertised as containing synthetic nicotine, has drawn attention
to the increasing use of synthetic nicotine in marketed products and its uncertain
regulatory status. A search of the Truth Tobacco Industry Documents revealed that
the industry considered using synthetic nicotine already in the 1960s, efforts that
were abandoned due to high costs and insufficient purity. Recent patents revealed
renewed efforts to develop more efficient strategies for the synthesis of nicotine.
Nicotine exists as two stereoisomers, <jats:italic>S</jats:italic>-nicotine and <jats:italic>R</jats:italic>-nicotine.
While <jats:italic>S</jats:italic>-nicotine is the prevalent (>99%) form of nicotine
in tobacco, a market-leading form of synthetic nicotine contains both stereoisomers
at equal amounts, raising concerns about inaccurate labelling and the poorly understood
health effects of <jats:italic>R</jats:italic>-nicotine. Other manufacturers, including
a leading vendor of pharmaceutical grade nicotine, developed stereospecific strategies
to synthesise pure <jats:italic>S</jats:italic>-nicotine, now added to electronic
cigarette products marketed in the USA and UK. While <jats:italic>S</jats:italic>-nicotine
and <jats:italic>R</jats:italic>-nicotine can be differentiated by enantioselective
High Performance Liquid Chromatography (HPLC), differentiation of synthetic (fossil-derived)
from tobacco-derived <jats:italic>S</jats:italic>-nicotine will require development
of methods to measure carbon isotope (<jats:sup>14</jats:sup>C or <jats:sup>13</jats:sup>C)
content. Vendors claim that the FDA has no authority to regulate synthetic nicotine
as a tobacco product, allowing them to circumvent the premarket tobacco product application
process. However, legal analysis suggests that FDA may have the authority to regulate
synthetic nicotine as a drug. Alternatively, Congress needs to include nicotine from
any source within the legal definition of tobacco products.</jats:p>
Type
Journal articlePermalink
https://hdl.handle.net/10161/23717Published Version (Please cite this version)
10.1136/tobaccocontrol-2021-056626Publication Info
Jordt, Sven-Eric (n.d.). Synthetic nicotine has arrived. Tobacco Control. 10.1136/tobaccocontrol-2021-056626. Retrieved from https://hdl.handle.net/10161/23717.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Sven Eric Jordt
Associate Professor in Anesthesiology
Research in the Jordt laboratory focuses on the mechanisms that enable humans and
animals to sense touch, pain and irritation. These fundamental sensations originate
in peripheral sensory neurons which contain signaling pathways that translate environmental
physical and chemical stimuli into neural activity. Our aims are to identify the molecular
components of these pathways and to understand how sensory neurons become activated
and sensitized during injury, inflammation and chronic painful c

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info